Aflac Named 2025 American Cancer Society Partner After Multimillion-Dollar Campaign
Aflac secured the American Cancer Society's 2025 Corporate Partner of the Year award after committing multimillion-dollar funds to joint fundraising, educational and advocacy initiatives. Its 2025 Check for Cancer campaign, launched after finding that 90% of Americans delay screenings, aims to increase early detection and bolster Aflac's ESG credentials.
1. Corporate Partnership Award
Aflac was honored as the American Cancer Society’s 2025 Corporate Partner of the Year in recognition of its exceptional collaboration on fundraising, educational programs, workplace wellness and national advocacy to advance cancer research and patient support.
2. Multimillion-Dollar Commitment and Screening Campaign
In 2025, Aflac launched a multimillion-dollar partnership with the American Cancer Society, including the Check for Cancer movement designed to turn everyday checkered patterns into reminders for screenings after its survey found that 90% of Americans delay health checkups that could save lives.
3. Brand Enhancement and ESG Impact
This award complements Aflac’s status as the No.1 U.S. supplemental health insurer and its inclusion on the World’s Most Ethical Companies list for 20 years and Fortune’s Most Admired Companies for 25 years, potentially strengthening its brand value and appeal to ESG-focused investors.